Global initiative for chronic obstructive lung disease

Journal of Cardiopulmonary Rehabilitation

Volumn 22, Issue 4, 2002, Pages 234-244

  Gerald, Lynn B ^a   Bailey, William C ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALMITRINE; ANTIBIOTIC AGENT; ANTIOXIDANT; ANTITUSSIVE AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOXAPRAM; GLUCOCORTICOID; INFLUENZA VACCINE; MUCOLYTIC AGENT; NARCOTIC AGENT; NITRIC OXIDE; OXYGEN; PNEUMOCOCCUS VACCINE; THEOPHYLLINE;

ARTIFICIAL VENTILATION; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE CONTROL; DRUG CONTRAINDICATION; HEALTH CARE COST; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; INCIDENCE; INFLUENZA VACCINATION; MORBIDITY; MORTALITY; OXYGEN THERAPY; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT MONITORING; PRACTICE GUIDELINE; PREVALENCE; PUBLIC HEALTH; REVIEW; RISK FACTOR; TOBACCO DEPENDENCE; TREATMENT OUTCOME;

EID: 0036631438     PISSN: 08839212     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008483-200207000-00004     Document Type: Review

References (98)

1. Obstructive lung disease deaths in the United States from 1979 through 1993
2. Characterization of the incidence and cost of COPD in the US
3. Current and future medical costs of asthma and chronic obstructive pulmonary disease in the Netherlands
4. The economic impact of asthma and COPD in Sweden 1980 and 1991
5. Antiproteases
6. Genetic-environment interactions in chronic airways obstruction
7. Is ABH nonsecretor status a risk factor for obstructive lung disease
8. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema
9. Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer
10. The molecular basis of alpha 1-antichymotrypsin deficiency in a heterozygote with liver and lung disease
11. Vitamin D-binding protein variants and the risk of COPD
12. Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis
13. Microsatellite DNA instability in COPD
14. Rate of decline of lung function in subjects with asthma
15. A 15-year follow-up study of ventilatory function in adults with asthma
16. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease
17. The natural history of forced expiratory volumes: Effect of cigarette smoking and respiratory symptoms
18. Smoking and other risk factors
19. Incidence, prevalence, and mortality: Intro- and intercountry differences
20. Epidemiology of chronic obstructive pulmonary disease
21. Quantitative relationships between cigarette smoking and chronic productive cough
22. An index of risk for obstructive airways disease
23. Occupational exposures: Evidence for a causal association with chronic obstructive pulmonary disease
24. Twelve-year spirometric changes among Paris area workers
25. Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study)
26. Passive smoking in obstructive respiratory disease in an industrialized urban population
27. Trends in COPD morbidity and mortality in the United States
28. International comparisons in COPD mortality
29. Smoking changes in smoking habits and rate of decline in FEV: New insight into gender differences
30. I: The Lung Health Study
31. Reassessment of inflammation of airways in chronic bronchitis
32. Small airways dimensions in asthma and in chronic obstructive pulmonary disease
33. The changes in airways structure associated with reduced forced expiratory volume in one second
34. Pathophysiology of chronic obstructive pulmonary disease
35. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease: Part two
36. Symptoms and signs of COPD
37. Ambient air pollution
38. "Sick of smoking": Evaluation of a targeted minimal smoking cessation intervention in general practice
39. The Tobacco Use and Dependence Clinical Practice Guideline Panel SaCR. A clinical practice guideline for treating tobacco use and dependence
40. Helping people to stop smoking: The new smoking cessation guidelines
41. Experimental evaluation of rehabilitation in chronic obstructive pulmonary disease: Short-term effects on exercise endurance and health status
42. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease
43. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: A randomised controlled trial
44. Randomised, double-blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
45. High-dose inhaled albuterol in severe chronic air-flow limitation
46. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease: A three-center study
47. Dose response relation to oral theophylline in severe chronic obstruction airways disease
48. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone: An 85-day multicenter trial
49. Routine nebulized ipratropium and albuterol together are better than either alone in COPD
50. Inhalation by nebulization of albuterol-ipratropium combination (Dey combination) is superior to either agent alone in the treatment of chronic obstructive pulmonary disease
51. Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease: A pilot study
52. Chronic bronchitis: The role of antibiotics
53. Management of acute exacerbation of chronic obstructive pulmonary disease
54. Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians
55. Oral diamorphine: Lack of effect on dyspnoea and exercise tolerance in the "pink puffer" syndrome
56. Effect of low-dose nebulised morphine on exercise endurance in patients with chronic lung disease
57. Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases
58. Effects of chronic administration of codeine and promethazine on breathlessness and exercise tolerance in patients with chronic airflow obstruction
59. The effect of sustained release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease
60. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease
61. No: COPD and beyond
62. Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction
63. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: A randomised controlled trial
64. The MOS 36-item short-form health survey (SF-36): 1. Conceptual framework and item selection
65. The St. George's respiratory questionnaire
66. Optimal assessment and management of chronic obstructive pulmonary disease (COPD)
67. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: A clinical trial
68. American Thoracic Society: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
69. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation: A consensus conference report
70. Indications for surgery and patient workup for bullectomy
71. Rationale and design of the National Emphysema Treatment Trial (NETT): A prospective randomized trial of lung volume reduction surgery
72. Lung transplantation
73. Lung transplantation comes of age
74. The registry of the International Society for Heart and Lung Transplantation: Fifteenth official report
75. Annual report of the US scientific registry for transplant recipients and the Organ Procurement and Transplantation Network
76. Prospective study of aetiology and outcome of adult lower respiratory tract infections in the community
77. Effect of viral infections on pulmonary function in patients with chronic obstructive pulmonary diseases
78. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation
79. The role of infection in COPD
80. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD
81. Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: Results from the APHEA project
82. Outcomes following acute exacerbation of severe chronic obstructive lung disease: The support investigators
83. Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease
84. Noninvasive positive pressure ventilation to treat respiratory failure
85. Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease
86. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease
87. Randomized prospective trial of noninvasive positive pressure ventilation in acute respiratory failure
88. Early use of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: A multicentre randomised controlled trial